Briefings

How can microdosing support people who experience ADHD, and does it work better than conventional medications? The first article explores this across two studies. We then venture into the heart of Europe, where psychedelic-assisted psychotherapy has been legally possible for the last decade (again). Finally, I’ll focus on the flexible repeated dosing in a trial with psilocybin for depression.

In the Research Briefing of February 14th: 1) Flashbacks are common in psychedelic research but participants don’t seem to mind 2) LSD influences creativity, breaking down thought patterns and relocating them toward the new 3) Psychedelics and society; thought on the past, present and future